- Home
- ROIV vs MHK Comparison
ROIV vs MHK Comparison
Compare ROIV & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- MHK
- Stock Information
- Founded
- ROIV 2014
- MHK 1988
- Country
- ROIV United Kingdom
- MHK United States
- Employees
- ROIV N/A
- MHK N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- MHK Home Furnishings
- Sector
- ROIV Health Care
- MHK Consumer Discretionary
- Exchange
- ROIV Nasdaq
- MHK Nasdaq
- Market Cap
- ROIV 8.4B
- MHK 7.2B
- IPO Year
- ROIV N/A
- MHK 1992
- Fundamental
- Price
- ROIV $10.79
- MHK $108.20
- Analyst Decision
- ROIV Buy
- MHK Buy
- Analyst Count
- ROIV 4
- MHK 14
- Target Price
- ROIV $17.50
- MHK $141.64
- AVG Volume (30 Days)
- ROIV 5.9M
- MHK 804.6K
- Earning Date
- ROIV 05-29-2025
- MHK 05-01-2025
- Dividend Yield
- ROIV N/A
- MHK N/A
- EPS Growth
- ROIV N/A
- MHK N/A
- EPS
- ROIV N/A
- MHK 7.66
- Revenue
- ROIV $122,585,000.00
- MHK $10,683,300,000.00
- Revenue This Year
- ROIV N/A
- MHK N/A
- Revenue Next Year
- ROIV N/A
- MHK $3.03
- P/E Ratio
- ROIV N/A
- MHK $14.07
- Revenue Growth
- ROIV 140.04
- MHK N/A
- 52 Week Low
- ROIV $8.73
- MHK $96.24
- 52 Week High
- ROIV $13.06
- MHK $164.29
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- MHK 52.47
- Support Level
- ROIV $10.58
- MHK $106.30
- Resistance Level
- ROIV $11.77
- MHK $114.36
- Average True Range (ATR)
- ROIV 0.34
- MHK 2.89
- MACD
- ROIV -0.07
- MHK 0.76
- Stochastic Oscillator
- ROIV 17.65
- MHK 57.40
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.